SABSW Sab Biotherapeutics, Inc.

Fundamentals / CIK 0001833214 / USD
Other share classes on CIK 0001833214: SABS

Sab Biotherapeutics, Inc. reported $0 in revenue and a net loss of $80.52M for the fiscal year ended December 31, 2025 (down 100.0% year over year).

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open SABSW in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$64.46M$32.23M$0-$44.63MFY 2020 Revenue: $55.24MFY 2020 Net Income: $20.12M2020FY 2021 Revenue: $60.88MFY 2021 Net Income: -$17.14M2021FY 2022 Revenue: $23.90MFY 2022 Net Income: -$18.74M2022FY 2023 Revenue: $2.24MFY 2023 Net Income: -$42.19M2023FY 2024 Revenue: $1.32MFY 2024 Net Income: -$34.11M2024FY 2025 Revenue: $0FY 2025 Net Income: $13.27M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $0 $1.32M $2.24M $23.90M $60.88M $55.24M
Research & Development $34.35M $30.25M $16.52M $36.44M $57.18M $27.91M
Total Operating Expenses $48.95M $44.23M $40.31M $52.82M $74.27M $34.68M
Operating Income -$48.95M -$42.91M -$38.08M -$28.92M -$13.39M $20.56M
EBITDA -$45.96M -$38.20M -$34.42M -$25.75M -$11.90M $20.94M
Interest Income $1.43M $1.29M $585K $71K $23K $26K
Interest Expense $241K $318K $315K $302K $294K $469K
Income Before Tax $13.27M -- -$42.19M -$18.72M -$17.14M $20.12M
Income Tax Expense $0 $0 $0 $26K $0 $0
Net Income $13.27M -$34.11M -$42.19M -$18.74M -$17.14M $20.12M
Basic EPS $0.22 -$3.68 -$7.64 -$4.31 -$6.30 $7.90
Diluted EPS -$0.79 -$3.68 -$7.64 -$4.31 -$6.30 $7.40
Basic Shares Outstanding 19.3M 9.3M 5.5M 4.4M 2.7M 2.5M
Diluted Shares Outstanding 61.3M 9.3M 5.5M 4.4M 2.7M 2.7M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue -- -- -- -- -- -- -- $115K
Research & Development $18.08M $16.17M $13.40M $10.73M $8.97M $7.00M $7.66M $7.65M
Total Operating Expenses $25.90M $23.38M $20.00M $15.77M $12.68M $9.73M $10.77M $10.12M
Operating Income -$25.90M -$23.38M -$20.00M -$15.77M -$12.68M -$9.73M -$10.77M -$10.01M
EBITDA -$25.10M -$22.58M -$19.27M -$15.03M -$11.98M -$8.93M -$10.02M -$9.24M
Interest Income -- $1.71M $1.05M $701K $655K $14K $62K $136K
Interest Expense -- $62K $63K $63K $43K $64K $70K $71K
Net Income -$22.30M -$22.49M -$18.87M -$16.86M $45.45M -$10.11M -$5.20M -$11.39M
Basic EPS -$0.24 -$0.28 -$0.35 -- $0.50 -$1.09 -$0.56 --
Diluted EPS -$0.24 -$0.28 -$0.35 -- -$0.21 -$1.09 -$0.56 --
Basic Shares Outstanding 93.2M 79.8M 53.6M -- 10.7M 9.3M 9.3M --
Diluted Shares Outstanding 93.2M 79.8M 53.6M -- 77.9M 9.3M 9.3M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Jun 30 Mar 31 Dec 31 Dec 31
Cash & Cash Equivalents $10.50M $8.90M $56.57M $15.05M $16.62M $22.41M $33.21M $12.61M
Short-Term Investments $86.09M $11.86M $0 -- -- -- -- --
Cash & Short-Term Investments $96.59M $20.76M $56.57M $15.05M $16.62M $22.41M $39.55M $12.61M
Accounts Receivable, Net -- -- $0 $5.56M $9.61M $11.79M $8.01M $20.57M
Total Current Assets $101.1M $23.79M $58.91M $22.10M $28.00M $37.18M $50.19M $34.46M
Property, Plant & Equipment, Net $13.31M $15.37M $19.74M $23.25M $24.84M $24.97M $24.31M $14.85M
Long-Term Investments $46.89M -- $0 -- -- -- -- --
Total Non-Current Assets $71.76M $20.40M $25.03M $28.81M $31.40M $31.30M $30.95M $22.08M
Total Assets $172.8M $44.20M $83.94M $50.90M $59.41M $68.49M $81.14M $56.54M
Accounts Payable $3.15M $1.69M $946K $3.68M $4.94M $4.98M $4.46M $7.38M
Total Current Liabilities $10.68M $7.98M $10.81M $14.99M $16.39M $19.27M $26.46M $11.06M
Total Non-Current Liabilities $10.63M $10.25M $15.83M $4.85M $5.90M $7.96M $16.14M $6.47M
Total Liabilities $21.32M $18.23M $26.64M $19.85M $22.29M $27.23M $42.59M $17.53M
Total Debt (incl. Leases) $5.95M $4.39M $4.86M $4.61M $6.07M $6.39M $6.72M $7.42M
Common Stock $5.0K $935 $929 $510 $4.4K $4.3K $4.3K $2.6K
Retained Earnings -$110.9M -$124.2M -$90.06M -$47.87M -$32.92M -$28.14M -$29.13M -$11.98M
Accumulated Other Comp. Income $187K -$135K $26K -- -- -- -- --
Total Stockholders' Equity $151.5M $25.97M $57.30M $31.06M $37.12M $41.26M $38.55M $39.01M
Total Equity $151.5M $25.97M $57.30M $31.06M $37.12M $41.26M $38.55M $39.01M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $14.44M $8.27M $20.52M $10.50M $29.42M $3.69M $5.64M $8.90M
Short-Term Investments $89.61M $94.36M $86.87M $86.09M $81.46M $2.02M $7.21M $11.86M
Cash & Short-Term Investments $104.0M $102.6M $107.4M $96.59M $110.9M $5.71M $12.85M $20.76M
Total Current Assets $107.7M $107.9M $112.8M $101.1M $113.3M $9.31M $16.30M $23.79M
Property, Plant & Equipment, Net $15.65M $14.23M $13.81M $13.31M $13.11M $13.86M $14.61M $15.37M
Long-Term Investments $101.3M $105.3M $110.2M $46.89M $50.61M -- -- --
Total Non-Current Assets $127.9M $130.3M $135.7M $71.76M $70.17M $20.82M $21.82M $20.40M
Total Assets $235.6M $238.2M $248.5M $172.8M $183.4M $30.13M $38.12M $44.20M
Accounts Payable $2.42M $3.85M $3.54M $3.15M $2.95M $2.62M $2.52M $1.69M
Total Current Liabilities $14.80M $11.71M $9.85M $10.68M $10.79M $10.68M $9.65M $7.98M
Total Non-Current Liabilities $9.93M $11.72M $11.37M $10.63M $7.58M $7.44M $7.06M $10.25M
Total Liabilities $24.72M $23.43M $21.22M $21.32M $18.37M $18.11M $16.71M $18.23M
Total Debt (incl. Leases) $4.92M $5.13M $6.17M $5.95M $6.19M $6.42M $6.64M $4.39M
Common Stock $9.0K $8.0K $7.6K $5.0K $4.8K $936 $936 $935
Retained Earnings -$174.6M -$152.3M -$129.8M -$110.9M -$94.03M -$139.5M -$129.4M -$124.2M
Accumulated Other Comp. Income -$2.30M -$930K -$223K $187K $71K -$16K -$112K -$135K
Total Stockholders' Equity $210.9M $214.8M $227.2M $151.5M $165.1M $12.02M $21.41M $25.97M
Total Equity $210.9M $214.8M $227.2M $151.5M $165.1M $12.02M $21.41M $25.97M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income $13.27M -$34.11M -$42.19M -$18.74M -$17.14M $20.12M
Depreciation & Amortization $2.99M $4.71M $3.65M $3.17M $1.49M $383K
Stock-Based Compensation $5.21M $2.94M $2.42M $2.67M $2.31M $1.30M
Change in Receivables -- -- $5.56M $2.45M $12.56M -$17.75M
Change in Payables $1.48M $923K -$2.70M -$779K -$2.94M $5.21M
Operating Cash Flow -$44.78M -$34.29M -$25.12M -$23.46M $1.99M $10.00M
Capital Expenditure -$933K -$337K -$197K -$2.17M -$10.94M -$12.73M
Free Cash Flow -$45.71M -$34.63M -$25.32M -$25.63M -$8.96M -$2.73M
Purchases of Investments -$142.0M -$37.45M -- -- -- --
Investing Cash Flow -$121.7M -$11.96M -$153K -$2.09M -$10.94M -$12.72M
Common Stock Issued -- -- -- $7.68M $0 $9.90M
Financing Cash Flow $168.3M -$1.17M $66.77M $1.05M $35.89M $8.98M
Net Change in Cash $1.60M -$47.67M $41.52M -$24.50M $26.93M $6.26M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$22.30M -$22.49M -$18.87M -$16.86M $45.45M -$10.11M -$5.20M -$11.39M
Depreciation & Amortization $800K $800K $731K $742K $700K $800K $757K $764K
Stock-Based Compensation $7.44M $7.25M $5.46M $3.17M $801K $627K $613K $674K
Change in Payables -$2.21M $675K $114K $325K $336K $138K $684K $590K
Operating Cash Flow -$13.02M -$9.84M -$14.27M -$16.78M -$13.05M -$7.15M -$7.80M -$9.53M
Capital Expenditure -$1.34M -$1.59M -$983K -- -- -- -- -$55K
Free Cash Flow -$14.37M -$11.43M -$15.25M -- -- -- -- -$9.59M
Purchases of Investments -$7.31M -$13.01M -$139.3M -$12.04M -$129.9M -$52K -$71K -$1.31M
Investing Cash Flow $6.07M -$4.88M -$65.65M -$1.71M -$129.9M $5.20M $4.67M $9.33M
Financing Cash Flow $13.00M $2.36M $89.92M -$42K $168.7M -$174K -$174K $217K
Net Change in Cash $6.17M -$12.25M $10.02M -$18.92M $25.73M -$1.95M -$3.26M -$273K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -- -3244.9% -1700.6% -121.0% -22.0% 37.2%
Net Profit Margin -- -2579.0% -1884.5% -78.4% -28.2% 36.4%
Return on Equity (ROE) 8.8% -131.3% -73.6% -60.3% -44.5% 51.6%
Return on Assets (ROA) 7.7% -77.2% -50.3% -36.8% -21.1% 35.6%
Current Ratio 9.46x 2.98x 5.45x 1.47x 1.90x 3.11x
Quick Ratio 9.04x 2.60x 5.23x 1.37x 1.80x 3.00x
Debt to Equity 0.04x 0.17x 0.08x 0.15x 0.17x 0.19x
Revenue Growth (YoY) -100.0% -40.9% -90.6% -60.7% +10.2% --
Operating Income Growth (YoY) -- -- -- -- -165.2% --
Net Income Growth (YoY) -- -- -- -- -185.2% --
EPS Growth (YoY) -- -- -- -- -179.7% --
Operating Cash Flow Growth (YoY) -- -- -- -1280.7% -80.1% --
5Y Revenue / Share Growth -100.0% -- -- -- -- --
5Y Net Income / Share Growth -91.3% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -- -- -- -- -- -- -- -3244.9%
Net Profit Margin -- -- -- -- -- -- -- -2579.0%
Return on Equity (ROE) -38.2% -5.9% -0.2% 8.8% 11.4% -308.4% -160.1% -131.3%
Return on Assets (ROA) -34.2% -5.4% -0.2% 7.7% 10.2% -123.0% -89.9% -77.2%
Current Ratio 7.28x 9.22x 11.45x 9.46x 10.50x 0.87x 1.69x 2.98x
Quick Ratio 7.03x 8.77x 10.90x 9.04x 10.27x 0.54x 1.33x 2.60x
Debt to Equity 0.02x 0.02x 0.03x 0.04x 0.04x 0.53x 0.31x 0.17x
Revenue Growth (YoY) -- -- -- -- -- -- -- -62.4%
Net Income Growth (YoY) -149.1% -- -- -- -- -- -- --
EPS Growth (YoY) -148.0% -- -- -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001833214) · from December 31, 2020 Data through September 30, 2026 · synced Nov 20, 2026, 05:41 UTC · Open in terminal